Skip to main content
Earnings Labs
Lipocine Inc. logo

Lipocine Inc. (LPCN)

NASDAQ·Healthcare·Biotechnology

$1.60

+1.91%

Mkt Cap $11.87M

Analyst Ratings

Buy

0

Hold

1

Sell

0

Price Target (3 analysts)

$6.00

Range $6.00 – $6.00

Implied Upside

+275.0%

Consensus $6.00 vs current $1.60